Fertility and Sterility, ISSN 0015-0282, 09/2017, Volume 108, Issue 3, pp. 407 - 415.e11
What progress has been made in fertility preservation (FP) over the last decade? FP techniques have been widely adopted over the last decade and therefore the...
Fertility preservation | embryo cryopreservation | fertoprotection | oncological fertility preservation | semen cryopreservation | oocyte cryopreservation | ovarian tissue cryopreservation | testicular tissue cryopreservation | non-oncological fertility preservation | CRYOPRESERVED OVARIAN TISSUE | STEM-CELLS | LIVE BIRTH | CHEMOTHERAPY | TRANSPLANTATION | OBSTETRICS & GYNECOLOGY | OOCYTE VITRIFICATION | WOMEN | REPRODUCTIVE BIOLOGY | GERM-CELLS | BREAST-CANCER PATIENTS | Prevalence | Humans | Infertility - prevention & control | Male | Treatment Outcome | Fertility Preservation - methods | Evidence-Based Medicine | Fertility Preservation - trends | Internationality | Female | Registries | Fertility Preservation - standards | Infertility - epidemiology | Practice Guidelines as Topic | Index Medicus
Fertility preservation | embryo cryopreservation | fertoprotection | oncological fertility preservation | semen cryopreservation | oocyte cryopreservation | ovarian tissue cryopreservation | testicular tissue cryopreservation | non-oncological fertility preservation | CRYOPRESERVED OVARIAN TISSUE | STEM-CELLS | LIVE BIRTH | CHEMOTHERAPY | TRANSPLANTATION | OBSTETRICS & GYNECOLOGY | OOCYTE VITRIFICATION | WOMEN | REPRODUCTIVE BIOLOGY | GERM-CELLS | BREAST-CANCER PATIENTS | Prevalence | Humans | Infertility - prevention & control | Male | Treatment Outcome | Fertility Preservation - methods | Evidence-Based Medicine | Fertility Preservation - trends | Internationality | Female | Registries | Fertility Preservation - standards | Infertility - epidemiology | Practice Guidelines as Topic | Index Medicus
Journal Article
Human Reproduction, ISSN 0268-1161, 09/2017, Volume 32, Issue 9, pp. 1802 - 1811
Abstract STUDY QUESTION What progress has been made in fertility preservation (FP) over the last decade? SUMMARY ANSWER FP techniques have been widely adopted...
Embryo cryopreservation | Ovarian tissue cryopreservation | Semen cryopreservation | Fertility preservation | Fertoprotection | Testicular tissue cryopreservation | Oocyte cryopreservation | Non-oncological fertility preservation | Oncological fertility preservation | CRYOPRESERVED OVARIAN TISSUE | STEM-CELLS | ISOLATED MURINE FOLLICLES | embryo cryopreservation | fertoprotection | LIVE BIRTH | oocyte cryopreservation | testicular tissue cryopreservation | OBSTETRICS & GYNECOLOGY | OOCYTE VITRIFICATION | REPRODUCTIVE BIOLOGY | oncological fertility preservation | PRESERVING FERTILITY | BREAST-CANCER PATIENTS | semen cryopreservation | IN-VITRO GROWTH | fertility preservation | ovarian tissue cryopreservation | HORMONE AGONIST | non-oncological fertility preservation | ESHRE Pages
Embryo cryopreservation | Ovarian tissue cryopreservation | Semen cryopreservation | Fertility preservation | Fertoprotection | Testicular tissue cryopreservation | Oocyte cryopreservation | Non-oncological fertility preservation | Oncological fertility preservation | CRYOPRESERVED OVARIAN TISSUE | STEM-CELLS | ISOLATED MURINE FOLLICLES | embryo cryopreservation | fertoprotection | LIVE BIRTH | oocyte cryopreservation | testicular tissue cryopreservation | OBSTETRICS & GYNECOLOGY | OOCYTE VITRIFICATION | REPRODUCTIVE BIOLOGY | oncological fertility preservation | PRESERVING FERTILITY | BREAST-CANCER PATIENTS | semen cryopreservation | IN-VITRO GROWTH | fertility preservation | ovarian tissue cryopreservation | HORMONE AGONIST | non-oncological fertility preservation | ESHRE Pages
Journal Article
FERTILITY AND STERILITY, ISSN 0015-0282, 09/2017, Volume 108, Issue 3
Study Question: What progress has been made in fertility preservation (FP) over the last decade? Summary Answer: FP techniques have been widely adopted over...
CRYOPRESERVED OVARIAN TISSUE | STEM-CELLS | Fertility preservation | ISOLATED MURINE FOLLICLES | embryo cryopreservation | fertoprotection | LIVE BIRTH | oocyte cryopreservation | testicular tissue cryopreservation | OBSTETRICS & GYNECOLOGY | OOCYTE VITRIFICATION | REPRODUCTIVE BIOLOGY | oncological fertility preservation | PRESERVING FERTILITY | BREAST-CANCER PATIENTS | semen cryopreservation | IN-VITRO GROWTH | ovarian tissue cryopreservation | HORMONE AGONIST | non-oncological fertility preservation
CRYOPRESERVED OVARIAN TISSUE | STEM-CELLS | Fertility preservation | ISOLATED MURINE FOLLICLES | embryo cryopreservation | fertoprotection | LIVE BIRTH | oocyte cryopreservation | testicular tissue cryopreservation | OBSTETRICS & GYNECOLOGY | OOCYTE VITRIFICATION | REPRODUCTIVE BIOLOGY | oncological fertility preservation | PRESERVING FERTILITY | BREAST-CANCER PATIENTS | semen cryopreservation | IN-VITRO GROWTH | ovarian tissue cryopreservation | HORMONE AGONIST | non-oncological fertility preservation
Journal Article
Geburtshilfe und Frauenheilkunde, ISSN 0016-5751, 06/2018, Volume 78, Issue 6, pp. 567 - 584
Abstract Aim The aim of this official guideline published by the German Society of Gynecology and Obstetrics (DGGG) and coordinated with the German Society of...
GebFra Science | oncologic diseases | STIMULATION | VITRIFICATION | RISK | CHEMOTHERAPY | OBSTETRICS & GYNECOLOGY | OVARIAN TISSUE CRYOPRESERVATION | guideline | BREAST-CANCER PATIENTS | fertility preservation | MUTATIONS | OUTCOMES | SURVIVORS | AGE
GebFra Science | oncologic diseases | STIMULATION | VITRIFICATION | RISK | CHEMOTHERAPY | OBSTETRICS & GYNECOLOGY | OVARIAN TISSUE CRYOPRESERVATION | guideline | BREAST-CANCER PATIENTS | fertility preservation | MUTATIONS | OUTCOMES | SURVIVORS | AGE
Journal Article
Clinical Pediatrics, ISSN 0009-9228, 04/2008, Volume 47, Issue 3, pp. 302 - 305
CHILDHOOD-CANCER | ONCOLOGY NURSES | IMPLEMENTATION | PEDIATRICS | OPTIONS | SURVIVORS | CARE | FEMALE | Tissue Preservation - methods | Humans | Tissue Preservation - standards | Male | Pediatric Nursing | Neoplasms - complications | Fertility | Medical Oncology - trends | Infertility, Female - etiology | Adult | Female | Ovum | Reproductive Medicine | Practice Guidelines as Topic | Tissue Preservation - utilization | Surveys | Prevention | Cancer patients | Care and treatment | Oncologic nursing | Infertility | Physiological aspects | Pediatric nursing | Risk factors | Preservation
Journal Article
Oncology Reports, ISSN 1021-335X, 05/2019, Volume 41, Issue 5, pp. 2607 - 2614
Survival rates in oncological patients have been steadily increasing in recent years due to the greater effectiveness of novel oncological treatments, such as...
Fertility preservation | Oncofertility | Female | Male | Prepuberal | Gonadotoxic treatment | Oncological treatment | CRYOPRESERVED OVARIAN TISSUE | METAANALYSIS | oncofertility | LIVE BIRTH | PREVENTION | gonadotoxic treatment | CHEMOTHERAPY | TRANSPLANTATION | PREGNANCY | oncological treatment | TESTICULAR SPERM EXTRACTION | ONCOLOGY | prepuberal | MEN | fertility preservation | female | CELL | male
Fertility preservation | Oncofertility | Female | Male | Prepuberal | Gonadotoxic treatment | Oncological treatment | CRYOPRESERVED OVARIAN TISSUE | METAANALYSIS | oncofertility | LIVE BIRTH | PREVENTION | gonadotoxic treatment | CHEMOTHERAPY | TRANSPLANTATION | PREGNANCY | oncological treatment | TESTICULAR SPERM EXTRACTION | ONCOLOGY | prepuberal | MEN | fertility preservation | female | CELL | male
Journal Article
Reproductive BioMedicine Online, ISSN 1472-6483, 2013, Volume 27, Issue 1, pp. 29 - 30
Abstract Improved possibilities to protect and preserve fertility before gonadotoxic therapies allow us to help more women than in previous years. But to...
Obstetrics and Gynecology | counselling | socio-demographic | ovary | cognitive | gonadotoxic | oncologic | REPRODUCTIVE BIOLOGY | OBSTETRICS & GYNECOLOGY | Decision Making | Female | Neoplasms - psychology | Referral and Consultation | Humans | Fertility Preservation
Obstetrics and Gynecology | counselling | socio-demographic | ovary | cognitive | gonadotoxic | oncologic | REPRODUCTIVE BIOLOGY | OBSTETRICS & GYNECOLOGY | Decision Making | Female | Neoplasms - psychology | Referral and Consultation | Humans | Fertility Preservation
Journal Article
ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, ISSN 1318-0347, 10/2011, Volume 80, Issue 10, pp. 766 - 774
Background: Advances in the diagnosis and treatment of malignancies in girls and young women had significantly increased survival rates, but surgical removal...
CONSERVATIVE TREATMENT | YOUNG-PATIENTS | CERVICAL-CANCER | CRYOPRESERVATION | oncologic patients | PREGNANCY | BREAST-CANCER | WOMEN | MEDICINE, GENERAL & INTERNAL | REPRODUCTIVE FUNCTION | OVARIAN TRANSPOSITION | fertility preservation | cryopreservation of genetic material | GRANULOSA-CELL TUMOR
CONSERVATIVE TREATMENT | YOUNG-PATIENTS | CERVICAL-CANCER | CRYOPRESERVATION | oncologic patients | PREGNANCY | BREAST-CANCER | WOMEN | MEDICINE, GENERAL & INTERNAL | REPRODUCTIVE FUNCTION | OVARIAN TRANSPOSITION | fertility preservation | cryopreservation of genetic material | GRANULOSA-CELL TUMOR
Journal Article
Geburtshilfe und Frauenheilkunde, ISSN 0016-5751, 06/2018, Volume 78, Issue 6, pp. 567 - 584
Journal Article
Geburtshilfe und Frauenheilkunde, ISSN 0016-5751, 06/2018, Volume 78, Issue 6, p. 567
The aim of this official guideline published by the German Society of Gynecology and Obstetrics (DGGG) and coordinated with the German Society of Urology (DGU)...
Journal Article
REVISTA DE CHIMIE, ISSN 0034-7752, 09/2019, Volume 70, Issue 9, pp. 3361 - 3363
In the last decades, by improving the oncological treatment, the life expectancy of the adolescent patients with ovarian cancer has been increased and more...
PRESERVATION | ENGINEERING, CHEMICAL | oncological treatment | ovarian cancer | future pregnancy | TISSUE | GROWTH | fertility conservation | RESTORATION | CHEMISTRY, MULTIDISCIPLINARY | TRANSPLANTATION
PRESERVATION | ENGINEERING, CHEMICAL | oncological treatment | ovarian cancer | future pregnancy | TISSUE | GROWTH | fertility conservation | RESTORATION | CHEMISTRY, MULTIDISCIPLINARY | TRANSPLANTATION
Journal Article
Human Reproduction Update, ISSN 1355-4786, 04/2016, Volume 22, Issue 3, pp. 281 - 305
BACKGROUND: The trend toward late childbearing has made fertility preservation a major issue for women who face gynecological cancer. New techniques in...
Oncological safety | Fertility preservation | Fertility sparing | Endometrial cancer | Gynaecological cancer | Cervical cancer | Assisted reproductive techniques | Ovarian cancer | COMPLEX ATYPICAL HYPERPLASIA | oncological safety | ovarian cancer | LONG-TERM SURVIVAL | assisted reproductive techniques | EARLY ENDOMETRIAL ADENOCARCINOMA | cervical cancer | EPITHELIAL OVARIAN-CANCER | MENOPAUSAL HORMONE-THERAPY | INTRACYTOPLASMIC SPERM INJECTION | OBSTETRICS & GYNECOLOGY | gynaecological cancer | REPRODUCTIVE BIOLOGY | EXTENDED FOLLOW-UP | fertility sparing | STAGE CERVICAL-CANCER | endometrial cancer | fertility preservation | IN-VITRO FERTILIZATION | VAGINAL RADICAL TRACHELECTOMY | Pregnancy | Reproductive Techniques, Assisted - adverse effects | Prospective Studies | Genital Neoplasms, Female - therapy | Humans | Female | Fertility Preservation - methods | Retrospective Studies
Oncological safety | Fertility preservation | Fertility sparing | Endometrial cancer | Gynaecological cancer | Cervical cancer | Assisted reproductive techniques | Ovarian cancer | COMPLEX ATYPICAL HYPERPLASIA | oncological safety | ovarian cancer | LONG-TERM SURVIVAL | assisted reproductive techniques | EARLY ENDOMETRIAL ADENOCARCINOMA | cervical cancer | EPITHELIAL OVARIAN-CANCER | MENOPAUSAL HORMONE-THERAPY | INTRACYTOPLASMIC SPERM INJECTION | OBSTETRICS & GYNECOLOGY | gynaecological cancer | REPRODUCTIVE BIOLOGY | EXTENDED FOLLOW-UP | fertility sparing | STAGE CERVICAL-CANCER | endometrial cancer | fertility preservation | IN-VITRO FERTILIZATION | VAGINAL RADICAL TRACHELECTOMY | Pregnancy | Reproductive Techniques, Assisted - adverse effects | Prospective Studies | Genital Neoplasms, Female - therapy | Humans | Female | Fertility Preservation - methods | Retrospective Studies
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2017, Volume 145, Issue 3, pp. 513 - 518
Abstract Objective To evaluate the oncologic and reproductive outcomes and to analyze prognostic factors after fertility-sparing surgery in patients with early...
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Ovary | Reproductive outcome | Oncologic outcome | Fertility-sparing surgery | Malignant ovarian germ cell tumor | YOLK-SAC TUMORS | CONSERVATIVE SURGERY | CANCER | CHEMOTHERAPY | OBSTETRICS & GYNECOLOGY | WOMEN | REPRODUCTIVE FUNCTION | ONCOLOGY | ENGLAND | Neoplasms, Germ Cell and Embryonal - mortality | Follow-Up Studies | Humans | Proportional Hazards Models | Treatment Outcome | Fertility Preservation - methods | Ovarian Neoplasms - mortality | Fertility Preservation - mortality | Pregnancy | Young Adult | Adult | Female | Neoplasms, Germ Cell and Embryonal - surgery | Retrospective Studies | Pregnancy Rate | Ovarian Neoplasms - surgery | Germ cell tumors | Analysis | Prognosis | Medical research | Medicine, Experimental | Medical records | Risk factors
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Ovary | Reproductive outcome | Oncologic outcome | Fertility-sparing surgery | Malignant ovarian germ cell tumor | YOLK-SAC TUMORS | CONSERVATIVE SURGERY | CANCER | CHEMOTHERAPY | OBSTETRICS & GYNECOLOGY | WOMEN | REPRODUCTIVE FUNCTION | ONCOLOGY | ENGLAND | Neoplasms, Germ Cell and Embryonal - mortality | Follow-Up Studies | Humans | Proportional Hazards Models | Treatment Outcome | Fertility Preservation - methods | Ovarian Neoplasms - mortality | Fertility Preservation - mortality | Pregnancy | Young Adult | Adult | Female | Neoplasms, Germ Cell and Embryonal - surgery | Retrospective Studies | Pregnancy Rate | Ovarian Neoplasms - surgery | Germ cell tumors | Analysis | Prognosis | Medical research | Medicine, Experimental | Medical records | Risk factors
Journal Article
International Journal of Clinical Oncology, ISSN 1341-9625, 4/2017, Volume 22, Issue 2, pp. 340 - 346
Trachelectomy was developed as a fertility-sparing surgery for early-stage cervical cancer in patients of childbearing age. The purpose of this study is to...
Oncologic outcomes | Medicine & Public Health | Trachelectomy | Obstetric outcomes | Oncology | Cancer Research | Surgical Oncology | Cervical cancer | Varix | ONCOLOGY | HYSTERECTOMY | VAGINAL RADICAL TRACHELECTOMY | Pregnancy Complications - etiology | Trachelectomy - adverse effects | Gynecologic Surgical Procedures - adverse effects | Humans | Uterine Cervical Neoplasms - surgery | Organ Sparing Treatments | Carcinoma, Squamous Cell - surgery | Abdomen - surgery | Fertility Preservation | Pregnancy | Young Adult | Adult | Female | Retrospective Studies | Pregnancy Outcome | Pregnancy Rate | Adenocarcinoma - surgery | Medical records | Pregnant women | Surgery
Oncologic outcomes | Medicine & Public Health | Trachelectomy | Obstetric outcomes | Oncology | Cancer Research | Surgical Oncology | Cervical cancer | Varix | ONCOLOGY | HYSTERECTOMY | VAGINAL RADICAL TRACHELECTOMY | Pregnancy Complications - etiology | Trachelectomy - adverse effects | Gynecologic Surgical Procedures - adverse effects | Humans | Uterine Cervical Neoplasms - surgery | Organ Sparing Treatments | Carcinoma, Squamous Cell - surgery | Abdomen - surgery | Fertility Preservation | Pregnancy | Young Adult | Adult | Female | Retrospective Studies | Pregnancy Outcome | Pregnancy Rate | Adenocarcinoma - surgery | Medical records | Pregnant women | Surgery
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2017, Volume 146, Issue 1, pp. 39 - 43
Highlights • We evaluated the influence of body weight change on progestin therapy outcomes. • A pretreatment BMI of ≥ 25 kg/m2 was predictive of poor response...
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Body weight change | Reproductive outcome | Oncologic outcome | Endometrial cancer | Progestin | Fertility-sparing | MORTALITY | MANAGEMENT | COMPLEX ATYPICAL HYPERPLASIA | MASS INDEX | ADENOCARCINOMA | RISK | PREMENOPAUSAL WOMEN | OBSTETRICS & GYNECOLOGY | REPRODUCTIVE OUTCOMES | ONCOLOGY | PHYSICAL-ACTIVITY | ORAL PROGESTIN | Body Mass Index | Antineoplastic Agents, Hormonal - administration & dosage | Humans | Body Weight - drug effects | Fertility Preservation - methods | Endometrial Neoplasms - physiopathology | Pregnancy | Megestrol Acetate - administration & dosage | Progestins - administration & dosage | Adult | Endometrial Neoplasms - drug therapy | Endometrial Neoplasms - pathology | Female | Medroxyprogesterone Acetate - administration & dosage | Retrospective Studies | Neoplasm Staging | Pregnancy Outcome | Pregnancy Rate | Women | Body weight | Young women | Cancer
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Body weight change | Reproductive outcome | Oncologic outcome | Endometrial cancer | Progestin | Fertility-sparing | MORTALITY | MANAGEMENT | COMPLEX ATYPICAL HYPERPLASIA | MASS INDEX | ADENOCARCINOMA | RISK | PREMENOPAUSAL WOMEN | OBSTETRICS & GYNECOLOGY | REPRODUCTIVE OUTCOMES | ONCOLOGY | PHYSICAL-ACTIVITY | ORAL PROGESTIN | Body Mass Index | Antineoplastic Agents, Hormonal - administration & dosage | Humans | Body Weight - drug effects | Fertility Preservation - methods | Endometrial Neoplasms - physiopathology | Pregnancy | Megestrol Acetate - administration & dosage | Progestins - administration & dosage | Adult | Endometrial Neoplasms - drug therapy | Endometrial Neoplasms - pathology | Female | Medroxyprogesterone Acetate - administration & dosage | Retrospective Studies | Neoplasm Staging | Pregnancy Outcome | Pregnancy Rate | Women | Body weight | Young women | Cancer
Journal Article